News & Updates

Sansanima closes seed investment round

by admin | October 2, 2025 | Announcements | 0 Comments

Sansanima closed a seed round backed by Sheffield Angels, o2h Ventures, and Cambridge Angels. Funding will advance validation, pilots, adoption.

by admin | October 1, 2025 | Publications & Media Mentions | 0 Comments

Elevate named Sansanima a Northern Gamechanger 2025. This recognises our work to replace animal testing in the manufacture of critical medicines.

by admin | September 2, 2025 | Publications & Media Mentions | 0 Comments

Understanding Animal Research featured an NC3Rs case study on Sansanima’s work. It highlights human relevant assays to replace animal tests today.

Oct 2, 2025 | Announcements

Sansanima closed a seed round backed by Sheffield Angels, o2h Ventures, and Cambridge Angels. Funding will advance validation, pilots, adoption.

Elevate named Sansanima a Northern Gamechanger 2025. This recognises our work to replace animal testing in the manufacture of critical medicines.

Understanding Animal Research featured an NC3Rs case study on Sansanima’s work. It highlights human relevant assays to replace animal tests today.

Aug 1, 2025 | Announcements

We joined the Cambridge Angels networking event to discuss partnerships and scale. Our focus was humane, specific, reproducible cell based assays.

Following strong public support, Dr Ciara Doran was named a top three finalist for ClimbUK Emerging Talent 2025. Thank you to everyone who voted.

Our CEO Dr Ciara Doran was nominated for ClimbUK Emerging Talent of the Year. This reflects momentum behind Sansanima’s humane testing platform.